Ligand Pharmaceuticals Incorporated (LGND)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
As of 03:47PM EDT. Market open.
| Previous close | 86.12 |
| Open | 85.53 |
| Bid | 86.53 x 100 |
| Ask | 87.11 x 100 |
| Day's range | 84.05 - 87.33 |
| 52-week range | 49.24 - 94.57 |
| Volume | |
| Avg. volume | 187,953 |
| Market cap | 1.56B |
| Beta (5Y monthly) | 0.92 |
| PE ratio (TTM) | 16.23 |
| EPS (TTM) | 5.35 |
| Earnings date | 06 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 02 July 2010 |
| 1y target est | 116.80 |
ZacksNektar's (NKTR) Q1 Earnings and Revenues Surpass Estimates
Nektar (NKTR) reports a narrower-than-expected loss in the first quarter of 2024 and tops revenue estimates.
ZacksInsmed (INSM) Beats on Q1 Earnings, Posts Upbeat Pipeline Updates
Insmed (INSM) Q1 earnings beat estimates while sales miss the mark. Management posts positive data readouts from mid-stage studies on its experimental inhalation powder in PH-ILD and PAH indications.
- Zacks
Iovance (IOVA) Q1 Earnings Surpass, Sales Lag Estimates
Iovance (IOVA) reports mixed first-quarter results. Shares gain on encouraging initial demand for the recently-approved melanoma drug Amtagvi in the United States.
© 2024 Yahoo. All rights reserved.